Summary
ABL Chart
Abbott Laboratories Q2 Earnings: Dividends Don't Lie
Abbott's Q2 performance reflects some evenness and the potential headwinds from macroeconomic uncertainties. However, short-term issues like tariffs and drug price control do not fundamentally alter Abbott's long-term moat. As a dividend aristocrat, its fundamental and valuation risks are better gauged by its dividend payouts than accounting EPS.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
ABT's Diabetes Care sales surge 19.6% in Q2, fueled by strong U.S. demand and new OTC approvals for its CGM systems.
Abbott Laboratories Dividends
 ABL 4 weeks ago Announced | Quarterly | €0.5 Per Share |
| ABL 9 months ago | Other | €0.55 Per Share |
| ABL 15 Jul 2024 | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
Abbott Laboratories Earnings
| 15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
| 14 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 17 Jul 2025 Date | | 1.26 Cons. EPS | - EPS |
| 16 Jul 2025 Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| ABL 4 weeks ago Announced | Quarterly | €0.5 Per Share |
| ABL 9 months ago | Other | €0.55 Per Share |
| ABL 15 Jul 2024 | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
| 15 Oct 2025 (In 2 months) Date | | 1.3 Cons. EPS | - EPS |
| 14 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 17 Jul 2025 Date | | 1.26 Cons. EPS | - EPS |
| 16 Jul 2025 Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
Abbott Laboratories (ABL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Robert B. Ford CEO | XFRA Exchange | US0028241000 ISIN |
| US Country | 114,000 Employees | 15 Jul 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
